{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T11:34:53Z","timestamp":1789644893477,"version":"4.0.0"},"reference-count":51,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Medical Economics"],"published-print":{"date-parts":[[2026,12,31]]},"DOI":"10.1080\/13696998.2026.2626239","type":"journal-article","created":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T14:41:38Z","timestamp":1771425698000},"page":"481-497","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":1,"title":["Time to access matters: patient gains from faster CAR T-cell reimbursement in Europe"],"prefix":"10.1080","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4266-1363","authenticated-orcid":false,"given":"Yan Zhi","family":"Tan","sequence":"first","affiliation":[{"name":"Lumanity","place":["Utrecht, Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Breislin","sequence":"additional","affiliation":[{"name":"Lumanity","place":["London, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Woods","sequence":"additional","affiliation":[{"name":"Lumanity","place":["London, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Madin-Warburton","sequence":"additional","affiliation":[{"name":"Lumanity","place":["London, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1642-2924","authenticated-orcid":false,"given":"Daniel","family":"Gladwell","sequence":"additional","affiliation":[{"name":"Lumanity","place":["London, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Zang","sequence":"additional","affiliation":[{"name":"Gilead","place":["Paris, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9138-8471","authenticated-orcid":false,"given":"Sachin","family":"Vadgama","sequence":"additional","affiliation":[{"name":"Kite a Gilead Company","place":["Santa Monica, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4948-8831","authenticated-orcid":false,"given":"Brett","family":"Doble","sequence":"additional","affiliation":[{"name":"Kite a Gilead Company","place":["Santa Monica, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Wiesinger","sequence":"additional","affiliation":[{"name":"Kite a Gilead Company","place":["Santa Monica, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8312-8178","authenticated-orcid":false,"given":"Oriol","family":"Sola-Morales","sequence":"additional","affiliation":[{"name":"Fundaci\u00f3 Health Innovation Technology Transfer (HiTT)","place":["Barcelona, Spain"]},{"name":"Universitat Internacional de Catalunya","place":["Barcelona, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,2,18]]},"reference":[{"key":"e_1_3_4_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-023-00754-1"},{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1177\/20406207221080738"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2022.05.006"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.1835"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-023-01334-y"},{"key":"e_1_3_4_7_1","unstructured":"Robert Hettle MC Hinde S Hodgson R et al. Exploring the assessment and appraisal of regenerative medicines and cell therapy products; 2016 [cited 2024 Oct 1]. https:\/\/www.nice.org.uk\/Media\/Default\/About\/what-we-do\/Science%20policy%20and%20research\/final-york-report-march-16.pdf."},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.3310\/hta21070"},{"key":"e_1_3_4_9_1","unstructured":"Golden D. Kymriah\u2019s 5-year survival data shows promise of CAR T-cell therapy; 2022 [cited 2024 Oct 1]. https:\/\/acgtfoundation.org\/news\/kymriah-survival-data-shows-promise-of-car-t-cell-therapy\/."},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-024-01530-z"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2023-174288"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/s43441-025-00769-z"},{"key":"e_1_3_4_13_1","unstructured":"European Federation of Pharmaceutical Industries and Associations. The root causes of unavailability of innovative medicines and delay in access: Shortening the wait. 2025 [cited 2025 May 1]. chrome-extension:\/\/efaidnbmnnnibpcajpcglclefindmkaj\/ https:\/\/www.efpia.eu\/media\/er5dshuq\/cra-efpia-root-causes-of-unavailability-and-delay-final-2025-report-29-apr-2025-stc.pdf."},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12082313"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1128295"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.915342"},{"key":"e_1_3_4_17_1","unstructured":"European Union. Regulation (EU) 2021\/2282 of the European Parliament and of the Council of 15 December 2021 on health technology assessment and amending Directive; 2011 [cited 2024 Nov 15]. https:\/\/eur-lex.europa.eu\/legal-content\/EN\/TXT\/?uri=CELEX:32021R2282."},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-023-09494-5"},{"key":"e_1_3_4_19_1","unstructured":"Statistia. Gross domestic product at current market prices of selected European countries in 2023; 2024 [cited 2024 Jan 1]. https:\/\/www.statista.com\/statistics\/685925\/gdp-of-european-countries\/."},{"key":"e_1_3_4_20_1","unstructured":"European Medicines Agency. Kymriah; 2024 [cited 2024 Nov 15]. https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/kymriah."},{"key":"e_1_3_4_21_1","unstructured":"European Medicines Agency. Yescarta; 2024 [cited 2024 Nov 15]. https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/yescarta."},{"key":"e_1_3_4_22_1","unstructured":"European Medicines Agency. Tecartus; 2024 [cited 2024 Nov 15]. https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/tecartus"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.51.5866"},{"key":"e_1_3_4_24_1","unstructured":"National Institute for Health and Care Excellence. Axicabtagene ciloleucel for treating diffuse large B-cell lymphoma and primary mediastinal large B-cell lymphoma after 2 or more systemic therapies; 2023 [cited 2024 Oct 1]. https:\/\/www.nice.org.uk\/guidance\/ta872\/history."},{"key":"e_1_3_4_25_1","unstructured":"National Institute for Health and Care Excellence. Tisagenlecleucel for treating relapsed or refractory B-cell acute lymphoblastic leukaemia in people aged up to 25 years. (MA review of TA554) ID6290]; 20241 [cited 2024 Oct 1]. https:\/\/www.nice.org.uk\/guidance\/ta975\/documents\/committee-papers"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.02370"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-198018"},{"key":"e_1_3_4_28_1","unstructured":"National Institute for Health and Care Excellence. Autologous anti-CD19-transduced CD3+ cells for treating relapsed or refractory mantle cell lymphoma. [ID1313]; 2024 [cited 2024 Oct 1]. https:\/\/www.nice.org.uk\/guidance\/ta677\/documents\/committee-papers"},{"key":"e_1_3_4_29_1","unstructured":"Central Statistics Office. Regional population projections; 2024 [cited 2024 Oct 1]. https:\/\/www.cso.ie\/en\/statistics\/population\/regionalpopulationprojections\/"},{"key":"e_1_3_4_30_1","unstructured":"Destatis. Estimate of the 2023 population based on the 2022 census; 2024 [cited 2024 Oct 1]. https:\/\/www.destatis.de\/EN\/Themes\/Society-Environment\/Population\/Current-Population\/estimate-population-based-census-2022.html."},{"key":"e_1_3_4_31_1","unstructured":"Institut national de la statistique et des \u00e9tudes \u00e9conomiques. Total population on 1st January - France (including Mayotte since 2014); 2024 [cited 2024 Oct 1]. https:\/\/www.insee.fr\/en\/statistiques\/serie\/001641586."},{"key":"e_1_3_4_32_1","unstructured":"Federal Statistical Office. Current situation and change; 2023 [cited 2024 Oct 1]. https:\/\/www.bfs.admin.ch\/bfs\/en\/home\/statistics\/population\/effectif-change.html."},{"key":"e_1_3_4_33_1","unstructured":"I.Stat. Resident population on 1st January; 2024 [cited 2024 Oct 1]. http:\/\/dati.istat.it\/?lang=en&SubSessionId=fe4777a9-297f-4fa3-9c70-d30a9db71e36&themetreeid=-200."},{"key":"e_1_3_4_34_1","unstructured":"Instituto Nacional de Estad\u00edstica. Population census 1 January 2023. 2024 [cited 2024 Oct 1]. https:\/\/ine.es\/en\/prensa\/censo_2022_2023_en.pdf"},{"key":"e_1_3_4_35_1","unstructured":"Office for National Statistics. Population estimates. 2023 [cited 2024 Oct 1]. https:\/\/www.ons.gov.uk\/peoplepopulationandcommunity\/populationandmigration\/populationestimates"},{"key":"e_1_3_4_36_1","unstructured":"Statistics Denmark. Population figures; 2024 [cited 2024 Oct 1]. https:\/\/www.dst.dk\/en\/Statistik\/emner\/borgere\/befolkning\/befolkningstal."},{"key":"e_1_3_4_37_1","unstructured":"Statistics Netherlands. Population dashboard. 2024 [cited 2024 Oct 1]. https:\/\/www.cbs.nl\/en-gb\/visualisations\/dashboard-population"},{"key":"e_1_3_4_38_1","unstructured":"Statistics Norway. Population; 2024 [cited 2024 Oct 1]. https:\/\/www.ssb.no\/en\/befolkning\/folketall\/statistikk\/befolkning"},{"key":"#cr-split#-e_1_3_4_39_1.1","unstructured":"Statistics Poland. Population. Size and structure and vital statistics in Poland by territorial division in 2023. As of 31 December"},{"key":"#cr-split#-e_1_3_4_39_1.2","unstructured":"2024 [cited 2024 Oct 1]. https:\/\/stat.gov.pl\/en\/topics\/population\/population\/population-size-and-structure-and-vital-statistics-in-poland-by-territorial-division-in-2023-as-of-31-december 3 35.html"},{"key":"e_1_3_4_40_1","unstructured":"Statistics Sweden. Population statistics; 2024 [cited 2024 Oct 1]. https:\/\/www.scb.se\/en\/finding-statistics\/statistics-by-subject-area\/population\/population-composition\/population-statistics\/"},{"key":"e_1_3_4_41_1","unstructured":"Haute Autorit\u00e9 de Sant\u00e9. Commission de la transparence - Yescarta; 2021 [cited 2024 Nov 1]. https:\/\/www.has-sante.fr\/upload\/docs\/evamed\/CT-19018_YESCARTA_PIC_REEV_AvisDef_CT19018.pdf"},{"key":"e_1_3_4_42_1","unstructured":"Haute Autorit\u00e9 de Sant\u00e9. \u00c9valuer les technologies de sant\u00e9 - Kymriah; 2023 [cited 2024 Nov 1]. https:\/\/www.has-sante.fr\/upload\/docs\/evamed\/CT-20264_KYMRIAH_LAL_PIC_REEV_AvisDef_CT20264.pdf"},{"key":"e_1_3_4_43_1","unstructured":"Haute Autorit\u00e9 de Sant\u00e9. Commission de la transparence - Tecartus; 2021 [cited 2024 Nov 1]. https:\/\/www.has-sante.fr\/upload\/docs\/evamed\/CT-19043_TECARTUS_PIC_INS_AvisDef_CT19043_EPI727.pdf."},{"key":"e_1_3_4_44_1","unstructured":"Programme de m\u00e9dicalisation du syst\u00e8me d\u2019informations (PMSI). National- Secteur MCO; 2018\u20132023 [2024 Oct 1]. Available from: https:\/\/www.atih.sante.fr\/analyse-de-l-activite-hospitaliere-2023"},{"key":"e_1_3_4_45_1","unstructured":"L\u00e6gemiddelindustriforeningen. Ny rapport kortl\u00e6gger adgangen til ATMP\u2019er i 11 europ\u00e6iske lande; 2024 [cited 2025 May 1]. https:\/\/www.lif.dk\/23549-2\/"},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.healthpol.2024.105153"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.hlpt.2023.100752"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-023-10443-5"},{"key":"e_1_3_4_49_1","unstructured":"IQVIA. Achieving CAR T-cell therapy health system readiness; 2025 [cited 2026 Jan 1]. https:\/\/www.iqvia.com\/-\/media\/iqvia\/pdfs\/institute-reports\/achieving-car-t-cell-therapy-health-system-readiness\/iqvia-institute-car-t-report-03-25-forweb.pdf."},{"key":"e_1_3_4_50_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-021-01070-1"},{"key":"e_1_3_4_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2024.11.019"}],"container-title":["Journal of Medical Economics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13696998.2026.2626239","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T14:47:59Z","timestamp":1772722079000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13696998.2026.2626239"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,18]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12,31]]}},"alternative-id":["10.1080\/13696998.2026.2626239"],"URL":"https:\/\/doi.org\/10.1080\/13696998.2026.2626239","relation":{},"ISSN":["1369-6998","1941-837X"],"issn-type":[{"value":"1369-6998","type":"print"},{"value":"1941-837X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,18]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-12-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-29","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-30","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-18","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}